"10.1371_journal.pone.0134102","plos one","2015-08-05T00:00:00Z","Ying-Hsia Chu; Huihua Li; Hui Shan Tan; Valerie Koh; Johnathan Lai; Wai Min Phyo; Yukti Choudhury; Ravindran Kanesvaran; Noan Minh Chau; Chee Keong Toh; Quan Sing Ng; Puay Hoon Tan; Balram Chowbay; Min-Han Tan","Institute of Bioengineering and Nanotechnology, Singapore, Republic of Singapore; Health Services Research, Singapore General Hospital, Singapore, Republic of Singapore; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Republic of Singapore; Department of Pathology, Singapore General Hospital, Singapore, Republic of Singapore; Laboratory of Clinical Pharmacology, Division Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore; Clinical Pharmacology Core, SingHealth, Singapore, Republic of Singapore; Clinical Sciences, Duke-NUS Graduate Medical School, Singapore, Republic of Singapore","Conceived and designed the experiments: YHC MHT. Performed the experiments: YHC VK JL WMP YC PHT. Analyzed the data: YHC HL MHT. Contributed reagents/materials/analysis tools: HST RK NMC CKT QSN PHT BC. Wrote the paper: YHC HL MHT.","MHT, YHC, JL, and PHT have filed for patents in molecular diagnostics. MHT has received research funding from Pfizer. RK is on the speaker bureau of Pfizer and a GlaxoSmithKline advisory board for pazopanib. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","08","Ying-Hsia Chu","YHC",14,TRUE,2,6,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
